| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 672,617 | 1,017,386 | ||
| Marketable securities | 1,015,200 | 971,764 | ||
| Trade and royalty receivables, net | 203,074 | 196,133 | ||
| Inventory, net | 52,688 | 34,061 | ||
| Prepaid expenses and other current assets | 64,224 | 53,531 | ||
| Total current assets | 2,007,803 | 2,272,875 | ||
| Fixed assets, net | 56,970 | 57,189 | ||
| Intangible assets, net | 396,466 | 143,806 | ||
| Goodwill | 82,341 | 82,341 | ||
| Operating lease rou assets | 80,682 | 56,162 | ||
| Deposits and other assets | 19,438 | 21,782 | ||
| Total assets | 2,643,700 | 2,634,155 | ||
| Accounts payable and accrued expenses | 303,141 | 338,945 | ||
| Current portion of long-term debt | 286,319 | - | ||
| Deferred revenue | 1,691 | 9,760 | ||
| Operating lease liabilities- current | 11,810 | 11,725 | ||
| Finance lease liabilities- current | 2,676 | 5,358 | ||
| Liability for sale of future royalties- current | 260,608 | 262,021 | ||
| Total current liabilities | 866,245 | 627,809 | ||
| Operating lease liabilities- noncurrent | 95,488 | 71,237 | ||
| Finance lease liabilities- noncurrent | 13,833 | 13,833 | ||
| Long-term debt | - | 286,013 | ||
| Liability for sale of future royalties- noncurrent | 1,821,313 | 1,833,985 | ||
| Other long-term liabilities | 2,579 | 7,824 | ||
| Total liabilities | 2,799,458 | 2,840,701 | ||
| Common stock, 0.001 par value. authorized 250,000,000 shares issued and outstanding 79,931,766 shares at september 30, 2025. authorized 250,000,000 shares issued and outstanding 77,704,188 shares at december 31, 2024 | 79 | 78 | ||
| Additional paid-in capital | 2,667,497 | 2,631,180 | ||
| Accumulated other comprehensive income (loss) | 5,930 | 7,356 | ||
| Accumulated deficit | -2,829,264 | -2,845,160 | ||
| Total stockholders' deficit | -155,758 | -206,546 | ||
| Total liabilities and stockholders' deficit | 2,643,700 | 2,634,155 | ||
PTC THERAPEUTICS, INC. (PTCT)
PTC THERAPEUTICS, INC. (PTCT)